GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS
CAUTION: Investigational device. Limited by United States law to investigational use.
Apr 12, 2022
CAUTION: Investigational device. Limited by United States law to investigational use.
Apr 12, 2022
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Provides Improved Outcomes in Real-World Peripheral Arterial Disease Cases
First Early Feasibility Study of a Gore Device Will Assess Treatment of Aortic Arch Aneurysms
Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone
Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy
First Successful Implants Providing Endovascular Repair to Iliac Arteries Completed in Australia
Company shares findings from the Global Registry for Endovascular Aortic Treatment (GREAT), the largest industry-sponsored registry of aortic stent grafts
New research methodology will procure real world feedback from surgeons and patients to improve outcomes with GORE® SYNECOR Biomaterial
Continually expanding clinicians’ options in the endovascular treatment of patients with aortic disease